INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 287
RESEARCH DOSSIER / NOT AN ENDORSEMENT

Holifya

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Programma medico per perdere peso in modo sicuro' (medical program to lose weight safely). Doctors, nutritionists and obesity specialists; GLP-1/GIP prescriptions if eligible; 'up to 20% body-weight loss with our support'; drugs prescribed in Italy under AIFA guidelines.

Audienceread

Italian patients with overweight/obesity seeking medically supervised GLP-1/GIP treatment.

Pricing & termspartial

Not captured from the Italian site in this pass; program includes specialist visits, nutritionist and psychologist support.

Clinical relationshipspartial

Holifya S.r.l. (Milan); specialist doctor, dedicated nutritionist and psychologists per patient; GLP-1/GIP prescribed only when clinically appropriate per AIFA guidelines.

Pharmacy & fulfillmentnot_found

Italian pharmacy dispensing; not named.

    Advertising snapshotpartial

    No confirmed ads in US-scoped Google/Meta lookups on 20 Oct 2026; LinkedIn returned 16 fuzzy matches with unverified attribution (Italian benefits/gym content). See dated channel evidence.

    Founding yearnot_found

    Not established in this pass.

      Foundersnot_found

      Not established in this pass.

        Location & entity contextverified

        Milan, Italy - Holifya S.r.l., Via Fetonte 12, 20151 Milano (site legal footer).

        Search visibility samplenot_found

        Not assessed in this pass.

          THE MODERN DOSING WEEKLY

          The peptide news
          that changes your week.

          Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.